Table 2 Binarized MRI features of ECC patients in death and survival groups
Imaging features | All samples (n = 104) | Death (n = 64) | Survival (n = 40) | p value |
|---|---|---|---|---|
Tumor size (> 3.2 cm) | 18 (17.3%) | 16 (25.0%) | 2 (5.0%) | 0.009 |
Lesion’s location (dCCA) | 63 (60.6%) | 36 (56.3%) | 27 (67.5%) | 0.253 |
Morphology | Â | Â | Â | 0.010 |
- Periductal infiltrating type | 44 (42.3%) | 25 (39.1%) | 19 (47.5%) | Â |
- Intraductal growth type | 43 (41.3%) | 23 (35.9%) | 20 (50.0%) | Â |
- Mass-forming type | 17 (16.3%) | 16 (25.0%) | 1 (2.5%) | Â |
Lesion’s signal (homogeneous) | 43 (41.3%) | 26 (40.6%) | 17 (42.5%) | 0.850 |
Intrahepatic bile duct dilatation (> 1.2 cm) | 52 (50.0%) | 33 (51.6%) | 19 (47.5%) | 0.687 |
DWI signal (high) | 80 (76.9%) | 51 (79.7%) | 29 (72.5%) | 0.397 |
ADCLesion (> 1.5 mm2/s) | 21 (20.2%) | 11 (17.2%) | 10 (25.0%) | 0.334 |
SIRLiver/Muscle (> 0.7) | 89 (85.6%) | 53 (82.8%) | 36 (90.0%) | 0.310 |
SIRSpleen/Muscle (> 1.9) | 61 (58.7%) | 34 (53.1%) | 27 (67.5%) | 0.148 |
SILiver (> 1.0) | 57 (54.8%) | 35 (54.7%) | 22 (55.0%) | 0.975 |
SISpleen (> 0.8) | 69 (66.3%) | 46 (71.9%) | 23 (57.5%) | 0.131 |